Planning Strategies Inc.’s Alnylam Pharmaceuticals ALNY Stock Holding History

Planning Strategies Inc.’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41K	Buy	+8	New	+$2.41K	﹤0.01%	551

Other funds holding ALNY

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Planning Strategies Inc.'s ALNY Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 8 shares worth $2.41K. The stake represents ﹤0.01% of the portfolio and ranks #551 among its holdings.

211 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Planning Strategies Inc. held 8 shares of Alnylam Pharmaceuticals worth $2.41K as of Q2 2026.
Alnylam Pharmaceuticals was a new Planning Strategies Inc. position in Q2 2026.
Alnylam Pharmaceuticals made up ﹤0.01% of Planning Strategies Inc.'s portfolio in Q2 2026, its #551 holding.
211 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.